宁波高发(603788) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was CNY 243,322,156.60, representing an increase of 11.78% compared to the same period last year[4] - The net profit attributable to shareholders decreased by 12.16% to CNY 37,890,347.79, while the net profit after deducting non-recurring gains and losses fell by 15.13% to CNY 34,086,851.12[4] - Basic and diluted earnings per share were both CNY 0.17, down 10.53% from the previous year[4] - Net profit for Q1 2022 was CNY 37,839,055.32, a decrease of 12.5% from CNY 43,136,973.34 in Q1 2021[14] - The total comprehensive income attributable to the parent company's owners for Q1 2022 was CNY 37,890,347.79, compared to CNY 43,136,973.34 in Q1 2021, reflecting a decrease of approximately 12.5%[15] Cash Flow - The net cash flow from operating activities was negative at CNY -32,337,389.96, a decrease of 6.71% year-on-year[4] - Cash inflows from operating activities totaled CNY 274,238,955.36 in Q1 2022, slightly up from CNY 271,657,049.43 in Q1 2021, representing an increase of approximately 0.6%[18] - The net cash flow from operating activities for Q1 2022 was -CNY 32,337,389.96, an improvement from -CNY 34,664,946.73 in Q1 2021, showing a reduction in losses of about 6.8%[18] - The total cash outflow from operating activities was CNY 306,576,345.32 in Q1 2022, slightly up from CNY 306,321,996.16 in Q1 2021, showing a marginal increase of about 0.1%[18] - The company did not report any cash inflows from financing activities in Q1 2022, indicating a potential focus on internal funding strategies[18] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,226,773,657.31, a decrease of 0.94% from the end of the previous year[4] - Total assets decreased to CNY 2,226,773,657.31 from CNY 2,247,916,842.70, a decline of 0.9%[11] - Total liabilities decreased to CNY 260,988,834.97 from CNY 319,971,075.68, a reduction of 18.4%[11] - The company's equity attributable to shareholders increased by 1.97% to CNY 1,965,436,278.38 compared to the end of the previous year[4] - The company's equity attributable to shareholders increased to CNY 1,965,436,278.38 from CNY 1,927,545,930.59, reflecting a growth of 2.0%[11] Research and Development - Research and development expenses increased by 29.62% due to higher direct material and personnel costs compared to the same period last year[6] - Research and development expenses for Q1 2022 were CNY 12,469,431.79, compared to CNY 9,620,286.77 in Q1 2021, marking an increase of 29.3%[14] Investment Income - Investment income surged by 343.84% as a result of more financial products maturing compared to the previous year[6] - The company reported cash received from the recovery of investments amounting to CNY 175,000,000.00 in Q1 2022, compared to CNY 50,000,000.00 in Q1 2021, indicating a growth of 250%[18] Other Financial Metrics - Non-recurring gains and losses totaled CNY 3,803,496.67, primarily from government subsidies and investment management income[6] - The company reported a 163.22% increase in credit impairment losses due to a rise in accounts receivable compared to the same period last year[6] - Total operating costs for Q1 2022 were CNY 202,055,927.51, up from CNY 169,855,841.09 in Q1 2021, reflecting a year-over-year increase of 18.9%[14] - The company's cash and cash equivalents as of March 31, 2022, were CNY 886,564,894.72, slightly down from CNY 900,131,436.68 at the end of 2021[10] - Accounts receivable increased to CNY 171,037,295.86 from CNY 158,894,648.35, representing an increase of 7.1%[10] - Inventory as of March 31, 2022, was CNY 182,230,504.56, up from CNY 170,522,319.44, indicating a growth of 6.4%[10]